- $12.65bn
- $12.02bn
- $1.40bn
U.S. STOCKS ON THE MOVE-Spotify, BlackRock, KLA Corp
Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
U.S. STOCKS ON THE MOVE-Spotify, BlackRock, Morgan Stanley
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
Boston Scientific to buy Penumbra in $14.5 billion deal (updated)
Penumbra jumps on Boston Scientific's $14.5 billion buyout deal
Boston Scientific to buy Penumbra in deal valued at $14.5 billion
U.S. RESEARCH ROUNDUP- Autozone, Coursera, Lennar
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Medical equipment maker Penumbra beats Q3 revenue estimates, raises revenue forecast
Brief: Penumbra Q3 Revenue USD 354.685 Million Vs. IBES Estimate USD 340.8 Million
Brief: Penumbra Names Shruthi Narayan As Company President
U.S. RESEARCH ROUNDUP-Penumbra, UnitedHealth, Visa
Penumbra Inc reports results for the quarter ended June 30 - Earnings Summary
Penumbra Q2 revenue up 13.4%, beats estimates
Analysis: Five years after COVID, pharma shares languish in US policy limbo
Analysis: Five years after COVID, pharma shares languish in US policy limbo
U.S. RESEARCH ROUNDUP- ServiceNow, Thermo Fisher Scientific, Watsco
U.S. RESEARCH ROUNDUP- ServiceNow, Thermo Fisher Scientific, Watsco